Difference between revisions of "Porter 2022 Abstract Bioblast"
m (Gnaiger Erich moved page Karavyraki 2022 Abstract Bioblast to Porter 2022 Abstract Bioblast) |
|||
Line 6: | Line 6: | ||
|year=2022 | |year=2022 | ||
|event=Bioblast 2022 | |event=Bioblast 2022 | ||
|abstract=In an endeavour to understand the metabolic phenotype behind | |abstract=In an endeavour to understand the metabolic phenotype behind oral squamous cell carcinomas [1], we characterised the bioenergetic profile of a human tongue derived cancer cell line (SCC-4 cells) and compared this profile to a pre-cancerous dysplastic oral keratinocyte (DOK) cell line also derived from human tongue. The human SCC-4 cancer cells had greater mitochondrial density but lower mitochondrial O<sub>2</sub> flow per cell ''J''<sub>O<sub>2</sub></sub> than DOK cells. The lower cell ''J''<sub>O<sub>2</sub></sub> in SCC-4 cells can be partially explained by lower NADH-related enzymatic activity when compared to pre-cancerous DOK cells. In addition, SCC-4 cells have greater extracellular acidification rate (an index of glycolytic flux) when compared to DOK cells. In addition, treatment with recombinant human IL-6 (rhIL-6), known to drive anoikis resistance in SCC-4 cells but not DOK cells, impairs oxygen consumption in SCC-4 but not DOK cells, without affecting mitochondrial density. We conclude that SCC-4 cells have a less oxidative phenotype compared to DOK cells and that IL-6 attenuates mitochondrial function in SCC-4 cells while increasing glycolytic flux. | ||
<small> | |||
# Karavyraki M, Porter RK (2022) Evidence of a role for interleukin-6 in anoikis resistance in oral squamous cell carcinoma. https://doi.org/10.1007/s12032-022-01664-5 | |||
</small> | |||
|keywords=Oral Squamous Cancer Cells, Mitochondria, Interleukin 6, Dysplastic oral keratinocytes, Oxygen consumption | |keywords=Oral Squamous Cancer Cells, Mitochondria, Interleukin 6, Dysplastic oral keratinocytes, Oxygen consumption |
Revision as of 08:37, 2 June 2022
Karavyraki M, Gnaiger E, Porter Richard K (2022) A comparison of bioenergetics in human tongue pre-cancerous dysplastic oral keratinocytes and squamous cancer cells. Bioblast 2022: BEC Inaugural Conference. |
Link: Bioblast 2022: BEC Inaugural Conference
Karavyraki Marilena, Gnaiger Erich, Porter Richard K (2022)
Event: Bioblast 2022
In an endeavour to understand the metabolic phenotype behind oral squamous cell carcinomas [1], we characterised the bioenergetic profile of a human tongue derived cancer cell line (SCC-4 cells) and compared this profile to a pre-cancerous dysplastic oral keratinocyte (DOK) cell line also derived from human tongue. The human SCC-4 cancer cells had greater mitochondrial density but lower mitochondrial O2 flow per cell JO2 than DOK cells. The lower cell JO2 in SCC-4 cells can be partially explained by lower NADH-related enzymatic activity when compared to pre-cancerous DOK cells. In addition, SCC-4 cells have greater extracellular acidification rate (an index of glycolytic flux) when compared to DOK cells. In addition, treatment with recombinant human IL-6 (rhIL-6), known to drive anoikis resistance in SCC-4 cells but not DOK cells, impairs oxygen consumption in SCC-4 but not DOK cells, without affecting mitochondrial density. We conclude that SCC-4 cells have a less oxidative phenotype compared to DOK cells and that IL-6 attenuates mitochondrial function in SCC-4 cells while increasing glycolytic flux.
- Karavyraki M, Porter RK (2022) Evidence of a role for interleukin-6 in anoikis resistance in oral squamous cell carcinoma. https://doi.org/10.1007/s12032-022-01664-5
β’ Keywords: Oral Squamous Cancer Cells, Mitochondria, Interleukin 6, Dysplastic oral keratinocytes, Oxygen consumption β’ Bioblast editor: Plangger M
Affiliations and support
- Marilena Karavyraki(1), Erich Gnaiger(2), Richard K Porter(1)
- School of Biochemistry, Trinity Biomedical Science Institute, Trinity College Dublin, Ireland - rkporter@tcd.ie
- Oroboros Instruments, Innsbruck, Austria
- Marilena Karavyraki(1), Erich Gnaiger(2), Richard K Porter(1)
- Acknowledgements: Marie Curie Grant TRACT 721906 H2020-MCSA-ITN 2016; COST Action CA15203 MitoEAGLE (2016-2021).
List of abbreviations, terms and definitions - MitoPedia
Labels: